Metraipolis › archive › dc_bb57802a7658
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses — Europe PMC PPR:PPR179735
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR179735
- DOI
- 10.1101/2020.06.22.20137695
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T08:21:42.409Z
- SHA-256 of the archived text
8339d47b2adc140a7d7f33f3ed9a447cea4c8c4c027eb330955f6863bd00bff6- Stable URL of this page
https://metraipolis.com/documento/dc_bb57802a7658
How to cite
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses — Europe PMC PPR:PPR179735 — Europe PMC, https://europepmc.org/article/PPR/PPR179735 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_bb57802a7658 (Metraipolis archive dc_bb57802a7658, sha256 8339d47b2adc140a7d7f33f3ed9a447cea4c8c4c027eb330955f6863bd00bff6)
BibTeX
@misc{dcbb57802a7658,
title = {Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses — Europe PMC PPR:PPR179735},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR179735},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_bb57802a7658; sha256 8339d47b2adc140a7d7f33f3ed9a447cea4c8c4c027eb330955f6863bd00bff6},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR179735. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
ABSTRACT: In order to properly understand the spread of SARS-CoV-2 infection and development of humoral immunity, researchers have evaluated the presence of serum antibodies of people worldwide experiencing the pandemic. These studies rely on the use of recombinant proteins from the viral genome in order to identify serum antibodies that recognize SARS-CoV-2 epitopes. Here, we discuss the cross-reactivity potential of SARS-CoV-2 antibodies with the full spike proteins of four other Betacoronaviruses that cause disease in humans, MERS-CoV, SARS-CoV, HCoV-OC43, and HCoV-HKU1. Using enzyme-linked immunosorbent assays (ELISAs), we detected the potential cross-reactivity of antibodies against SARS-CoV-2 towards the four other coronaviruses, with the strongest cross-recognition between SARS-CoV-2 and SARS /MERS-CoV antibodies, as expected based on sequence homology of their respective spike proteins. Further analysis of cross-reactivity could provide informative data that could lead to intelligently designed pan-coronavirus therapeutics or vaccines. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2020 (prima pubblicazione 2020-06-23). Identificativi: DOI 10.1101/2020.06.22.20137695. Pagina: https://europepmc.org/article/PPR/PPR179735 — https://doi.org/10.1101/2020.06.22.20137695. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T08:16:12.058Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.